Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07401966

Amputations in Childhood and Neuropathic Pain

This observational study aims to assess the presence of neuropathic pain in children and adolescents who underwent limb amputation during childhood.

The study focuses on two types of neuropathic pain: phantom limb pain and residual limb pain. It also evaluates quality of life and functional autonomy in this population and explores potential associations between neuropathic pain, autonomy, quality of life, and age at amputation.

Using a mixed retrospective and prospective design, data are collected from medical records and standardized questionnaires administered during routine follow-up visits at a specialized pediatric limb anomaly center. The study seeks to improve understanding of neuropathic pain after pediatric amputation and its impact on daily functioning.

Recruiting

Interested in participating?

Request Info

Key information

Age range

5 year–18 year

Sex eligibility

All sexes

Study type

Observational

Primary location

About this study

Pediatric limb amputations are rare and may occur in the context of trauma, infection, tumors, or congenital malformations. In some congenital conditions, such as proximal femoral focal deficiency, therapeutic amputation may be proposed to improve prosthetic fitting, functional outcomes, and autonomy. One of the potential complications associated with limb amputation is the development of neuropathic pain, including phantom limb pain and residual limb pain. While these conditions are well documented in adults, their prevalence and impact in pediatric populations remain poorly understood.

Neuropathic pain may interfere with prosthetic use, functional abilities, quality of life, and long-term autonomy. In children who undergo amputation for functional purposes, the presence and consequences of neuropathic pain are important factors to consider when weighing the expected benefits of surgery. Early identification and management of neuropathic pain may also allow better anticipation and implementation of preventive or therapeutic strategies.

This monocentric observational study aims to describe the presence of neuropathic pain in children and adolescents who underwent limb amputation during childhood. Neuropathic pain is assessed using validated questionnaires, distinguishing between phantom limb pain and residual limb pain. The study also evaluates quality of life and functional autonomy using age-appropriate standardized assessment tools.

In addition, the study explores associations between neuropathic pain and functional autonomy, quality of life, age at amputation, and preoperative preventive treatments when applicable. Data are collected through a mixed retrospective and prospective approach, combining extraction of medical record information and a single administration of questionnaires during routine follow-up visits. No intervention or modification of standard clinical care is performed.

By providing descriptive data on neuropathic pain and its functional consequences after pediatric amputation, this study aims to contribute to improved clinical decision-making, pain management strategies, and long-term follow-up of children with limb amputations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients aged between 5 and 18 years (inclusive) (Piaget's concrete operational stage to be able to complete the self-assessment questionnaires)
  • Patients who underwent amputation before the age of 15 for girls and 16 for boys (average age of completion of lower limb growth)
  • Patients who have not undergone surgery on the amputated limb for at least one year (to avoid bias, as any surgery involving incision can cause temporary neuropathic pain unrelated to the amputation)
  • Have obtained the signature of the non-objection form by both parents/legal guardians
  • Have obtained the child's consent (verbal consent but recorded)
  • Be affiliated with a health insurance plan.

Exclusion criteria

  • Patients who do not speak French
  • Patients whose cognitive abilities are insufficient (as determined by a clinician or reported by parents) to be able to complete self-assessment questionnaires
  • Patients undergoing chemotherapy (due to transient neuropathic pain)
  • Patients who have received chemotherapy and whose side effects have not yet subsided (on a case-by-case basis depending on the chemotherapy used)
  • Patients who have received chemotherapy causing neuropathic pain due to this treatment that has not disappeared.
  • Patients placed under protective custody.

Treatment and study plan

Primary outcomes

  1. Presence of neuropathic pain after pediatric limb amputation

    Time frame: Single assessment at study inclusion (variable time after amputation)

    Presence of neuropathic pain assessed using the DN4 questionnaire, including phantom limb pain and residual limb pain. A DN4 score of 4 or higher is considered indicative of neuropathic pain.

Secondary outcomes

  1. Type of neuropathic pain after pediatric limb amputation

    Time frame: At study inclusion

    Type of neuropathic pain reported after limb amputation, distinguishing phantom limb pain and residual limb pain, assessed using the DN4 questionnaire.

  2. Health-related quality of life

    Time frame: At study inclusion

    Health-related quality of life assessed using the SF-15 Generic Core Scales questionnaire, adapted to the participant's age, in children and adolescents with limb amputation.

  3. Locomotor capability in lower limb amputees

    Time frame: At study inclusion

    Locomotor capability assessed using the Locomotor Capability Index (LCI) in children and adolescents with lower limb amputation. The LCI score is analyzed in prosthesis users, for whom the scale is validated. For non-prosthesis users, a descriptive analysis of individual items is performed.

  4. Upper limb functional ability

    Time frame: At study inclusion

    Upper limb functional ability assessed using the Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH) questionnaire in children and adolescents with upper limb amputation.

  5. Correlation between DN4 neuropathic pain score and SF-15 health-related quality of life score

    Time frame: At study inclusion

    Neuropathic pain will be assessed using the Douleur Neuropathique 4 (DN4) questionnaire (score range 0-10; score ≥4 indicating neuropathic pain).

    Health-related quality of life will be assessed using the SF-15 Generic Core Scales questionnaire (score range 0-100; higher scores indicating better quality of life).

    The correlation between DN4 total score (continuous variable) and SF-15 total score (continuous variable) will be analyzed using Pearson or Spearman correlation coefficients, as appropriate.

    The strength of correlation will be expressed as Pearson or Spearman correlation coefficient (r), ranging from -1 to +1.

  6. Correlation between DN4 neuropathic pain score and functional outcome scores (LCI and QuickDASH)

    Time frame: At study inclusion

    Neuropathic pain will be assessed using the Douleur Neuropathique 4 (DN4) questionnaire (score range 0-10; higher scores indicate greater neuropathic pain).

    Functional outcomes will be assessed using:

    Locomotor Capability Index (LCI) in lower limb amputees (score range 0-100; higher scores indicate better locomotor capability) Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH) questionnaire in upper limb amputees (score range 0-100; higher scores indicate greater disability).

    Correlations between DN4 total score and functional outcome scores will be analyzed using Pearson or Spearman correlation coefficients (r).

  7. Correlation between DN4 neuropathic pain score and age at amputation

    Time frame: At study inclusion

    Neuropathic pain will be assessed using the Douleur Neuropathique 4 (DN4) questionnaire (score range 0-10; higher scores indicate greater neuropathic pain).

    Age at amputation (years) will be recorded from medical records. Correlation between DN4 total score and age at amputation will be analyzed using Pearson or Spearman correlation coefficients (r).

Study contacts

Contact information is provided by the study sponsor or research team.

Auriane AS SLAMA

CONTACT

[email protected]

+33143967556 ext. +33607317969

Sponsors and collaborators

Lead sponsor

Hopitaux de Saint-Maurice

Other

Registry information

Acronym: NAPE

Important dates

Study start
2026
Primary completion
2026
Study completion
2027
First posted
Feb 11, 2026
Registry last updated
Feb 23, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.